290 related articles for article (PubMed ID: 17976332)
1. Percutaneous stenting of superior vena cava syndrome: treatment outcome in patients with benign and malignant etiology.
Barshes NR; Annambhotla S; El Sayed HF; Huynh TT; Kougias P; Dardik A; Lin PH
Vascular; 2007; 15(5):314-21. PubMed ID: 17976332
[TBL] [Abstract][Full Text] [Related]
2. Follow-up results of 71 patients undergoing metallic stent placement for the treatment of a malignant obstruction of the superior vena cava.
Nagata T; Makutani S; Uchida H; Kichikawa K; Maeda M; Yoshioka T; Anai H; Sakaguchi H; Yoshimura H
Cardiovasc Intervent Radiol; 2007; 30(5):959-67. PubMed ID: 17546400
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous treatment of superior vena cava syndrome using metallic stents.
de Gregorio Ariza MA; Gamboa P; Gimeno MJ; Alfonso E; Mainar A; Medrano J; López-Marin P; Tobio R; Herrera M
Eur Radiol; 2003 Apr; 13(4):853-62. PubMed ID: 12664126
[TBL] [Abstract][Full Text] [Related]
4. Use of self-expanding vascular endoprostheses in superior vena cava syndrome.
García Mónaco R; Bertoni H; Pallota G; Lastiri R; Varela M; Beveraggi EM; Vassallo BC
Eur J Cardiothorac Surg; 2003 Aug; 24(2):208-11. PubMed ID: 12895609
[TBL] [Abstract][Full Text] [Related]
5. Endovascular treatment of malignant superior vena cava syndrome: is bilateral wallstent placement superior to unilateral placement?
Dinkel HP; Mettke B; Schmid F; Baumgartner I; Triller J; Do DD
J Endovasc Ther; 2003 Aug; 10(4):788-97. PubMed ID: 14533962
[TBL] [Abstract][Full Text] [Related]
6. Endovascular treatment of malignant superior vena cava syndrome secondary to lung cancer.
Calsina Juscafresa L; Gil Bazo I; Grochowicz L; Páramo Alfaro M; López-Picazo González JM; Moreno Jiménez M; Bilbao Jaureguizar JI
Hosp Pract (1995); 2017 Aug; 45(3):70-75. PubMed ID: 28618844
[TBL] [Abstract][Full Text] [Related]
7. Endovascular stenting in the management of malignant superior vena cava obstruction: comparing safety, effectiveness, and outcomes between primary stenting and salvage stenting.
Leung ST; Sung TH; Wan AY; Leung KW; Kan WK
Hong Kong Med J; 2015 Oct; 21(5):426-34. PubMed ID: 26139689
[TBL] [Abstract][Full Text] [Related]
8. Stent placement for the treatment of malignant superior vena cava syndrome - a single-center series of 56 patients.
Sobrinho G; Aguiar P
Arch Bronconeumol; 2014 Apr; 50(4):135-40. PubMed ID: 24360084
[TBL] [Abstract][Full Text] [Related]
9. Stenting as first option for endovascular treatment of malignant superior vena cava syndrome.
Lanciego C; Chacón JL; Julián A; Andrade J; López L; Martinez B; Cruz M; García-García L
AJR Am J Roentgenol; 2001 Sep; 177(3):585-93. PubMed ID: 11517051
[TBL] [Abstract][Full Text] [Related]
10. [Effectiveness of endovascular prostheses as initial treatment for superior vena cava syndrome of malignant cause].
Talens A; Ferrer S; González-Cruz A; Blanco E; García-Ferrer L; Iranzo V; Camps C
Med Clin (Barc); 2013 Jan; 140(2):59-65. PubMed ID: 22237043
[TBL] [Abstract][Full Text] [Related]
11. Endovascular stenting for treatment of superior vena cava syndrome.
Karaca O; Akçakoyun M; Esen O; Esen AM
Turk Kardiyol Dern Ars; 2009 Sep; 37(6):414-6. PubMed ID: 20019457
[TBL] [Abstract][Full Text] [Related]
12. Endovascular stenting for end-stage lung cancer patients with superior vena cava syndrome post first-line treatments - A single-center experience and literature review.
Kuo TT; Chen PL; Shih CC; Chen IM
J Chin Med Assoc; 2017 Aug; 80(8):482-486. PubMed ID: 28501315
[TBL] [Abstract][Full Text] [Related]
13. Endovascular stenting as the first step in the overall management of malignant superior vena cava syndrome.
Lanciego C; Pangua C; Chacón JI; Velasco J; Boy RC; Viana A; Cerezo S; García LG
AJR Am J Roentgenol; 2009 Aug; 193(2):549-58. PubMed ID: 19620456
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous stenting of superior vena cava syndrome: a case report and review of the literature.
Hochrein J; Bashore TM; O'Laughlin MP; Harrison JK
Am J Med; 1998 Jan; 104(1):78-84. PubMed ID: 9528723
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous endovascular management of chronic superior vena cava syndrome of benign causes : long-term follow-up.
Breault S; Doenz F; Jouannic AM; Qanadli SD
Eur Radiol; 2017 Jan; 27(1):97-104. PubMed ID: 27085696
[TBL] [Abstract][Full Text] [Related]
16. Kissing Viabahn VBX stent graft reconstruction of thoracic central veins for management of superior vena cava syndrome.
Shin DS; Jackson TR; Bertino FJ; Monroe EJ; Hage AN; Lee E; Ingraham CR; Vaidya S; Chick JFB
J Vasc Surg Venous Lymphat Disord; 2022 Nov; 10(6):1279-1287.e1. PubMed ID: 35843595
[TBL] [Abstract][Full Text] [Related]
17. Stent Implantation for Superior Vena Cava Syndrome of Malignant Cause.
Büstgens FA; Loose R; Ficker JH; Wucherer M; Uder M; Adamus R
Rofo; 2017 May; 189(5):423-430. PubMed ID: 28152555
[No Abstract] [Full Text] [Related]
18. Percutaneous endovascular Y-stenting of a malignant superior vena cava and innominate vein obstruction.
Cordial R; Moussavian MR; Corvalan J; Görtz H; Teßarek J
Vasc Endovascular Surg; 2014 Jan; 48(1):77-9. PubMed ID: 24122722
[TBL] [Abstract][Full Text] [Related]
19. Percutaneous transluminal stenting for superior vena cava syndrome caused by malignant tumors: a single-center retrospective study.
Liu H; Li Y; Wang Y; Yan L; Zhou P; Han X
J Cardiothorac Surg; 2021 Mar; 16(1):39. PubMed ID: 33743767
[TBL] [Abstract][Full Text] [Related]
20. Literature Review of Percutaneous Stenting for Palliative Treatment of Malignant Superior Vena Cava Syndrome (SVCS).
Léon D; Rao S; Huang S; Sheth R; Yevich S; Ahrar K; Huynh T; Pisimisis G; Kuban JD
Acad Radiol; 2022 Apr; 29 Suppl 4():S110-S120. PubMed ID: 34602363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
